Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 218 participants.

Also called NCT06441539

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 218 participants (planned count) (from the registry)
Sponsor
Yinyi(Liaoning) Biotech Co., Ltd. (from the registry)
Registry
  • NCT NCT06441539
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06441539. Randomized; no masking; primary purpose treatment. Start 2024-07-01 (anticipated); primary completion 2025-02-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions
Intervention (Device)
Bingo® Paclitaxel coated balloon
Intervention (Device)
Xience® Alpine Everolimus Eluting Coronary Stent System
Lead sponsor
Yinyi(Liaoning) Biotech Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct06441539
Content hash
4fce3630a91a3761eccca091d8d16d448c2399f84023bb5f68176f012087893a